NeuroDerm To Raise $58M In Secondary Offering

July 15, 2015 | The Israeli company developing a treatment for Parkinson’s Disease, NeuroDerm announced that it plans to raise $58 million in its secondary offering. The company plans to raise the said amount, including green shoe options, at a share price of $15.60. NeuroDerm held its IPO in November of 2014, in which it raised $45 million. Since, the share price has risen by nearly 60 percent, bringing the company’s market cap to $272 million. NeuroDerm was founded in 2003 and is based out of Rehovot.